202 related articles for article (PubMed ID: 36444917)
21. Myocardial collagen deposition and inflammatory cell infiltration in cats with pre-clinical hypertrophic cardiomyopathy.
Khor KH; Campbell FE; Owen H; Shiels IA; Mills PC
Vet J; 2015 Feb; 203(2):161-8. PubMed ID: 25573453
[TBL] [Abstract][Full Text] [Related]
22. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts.
Schlittler M; Pramstaller PP; Rossini A; De Bortoli M
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834293
[TBL] [Abstract][Full Text] [Related]
23. Collective transcriptomic deregulation of hypertrophic and dilated cardiomyopathy - Importance of fibrotic mechanism in heart failure.
Malgija B; Kumar NS; Piramanayagam S
Comput Biol Chem; 2018 Apr; 73():85-94. PubMed ID: 29471264
[TBL] [Abstract][Full Text] [Related]
24. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction.
Fassbach M; Schwartzkopff B
Z Kardiol; 2005 May; 94(5):328-35. PubMed ID: 15868361
[TBL] [Abstract][Full Text] [Related]
26. Translational investigation of electrophysiology in hypertrophic cardiomyopathy.
Flenner F; Jungen C; Küpker N; Ibel A; Kruse M; Koivumäki JT; Rinas A; Zech ATL; Rhoden A; Wijnker PJM; Lemoine MD; Steenpass A; Girdauskas E; Eschenhagen T; Meyer C; van der Velden J; Patten-Hamel M; Christ T; Carrier L
J Mol Cell Cardiol; 2021 Aug; 157():77-89. PubMed ID: 33957110
[TBL] [Abstract][Full Text] [Related]
27. Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.
Shih YC; Chen CL; Zhang Y; Mellor RL; Kanter EM; Fang Y; Wang HC; Hung CT; Nong JY; Chen HJ; Lee TH; Tseng YS; Chen CN; Wu CC; Lin SL; Yamada KA; Nerbonne JM; Yang KC
Circ Res; 2018 Apr; 122(8):1052-1068. PubMed ID: 29535165
[TBL] [Abstract][Full Text] [Related]
28. Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy.
Almaas VM; Haugaa KH; Strøm EH; Scott H; Dahl CP; Leren TP; Geiran OR; Endresen K; Edvardsen T; Aakhus S; Amlie JP
Europace; 2013 Sep; 15(9):1319-27. PubMed ID: 23426552
[TBL] [Abstract][Full Text] [Related]
29. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.
Marian AJ; Tan Y; Li L; Chang J; Syrris P; Hessabi M; Rahbar MH; Willerson JT; Cheong BY; Liu CY; Kleiman NS; Bluemke DA; Nagueh SF
Circ Res; 2018 Apr; 122(8):1109-1118. PubMed ID: 29540445
[TBL] [Abstract][Full Text] [Related]
30. [Myocardial biopsy of Liwen procedure: representability and etiological diagnostic value of cardiac samples obtained by a novel technique in patients with hypertrophic cardiomyopathy].
Han C; Zhou MY; Wu JF; Wang B; Ma H; Hu R; Zuo L; Li J; Li XJ; Ta SJ; Fan LN; Liu LW
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Apr; 50(4):361-368. PubMed ID: 35399032
[No Abstract] [Full Text] [Related]
31. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
[TBL] [Abstract][Full Text] [Related]
32. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
[TBL] [Abstract][Full Text] [Related]
33. Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.
Krishnan A; Li X; Kao WY; Viker K; Butters K; Masuoka H; Knudsen B; Gores G; Charlton M
Lab Invest; 2012 Dec; 92(12):1712-25. PubMed ID: 23007134
[TBL] [Abstract][Full Text] [Related]
34. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Hernández-Romero D; Orenes-Piñero E; García-Honrubia A; Climent V; Romero-Aniorte AI; Martínez CM; García-Bautista M; Martínez M; Feliu E; González J; Cánovas S; Montero-Argudo JA; Valdés M; Marín F
J Intern Med; 2015 Jul; 278(1):50-8. PubMed ID: 25476756
[TBL] [Abstract][Full Text] [Related]
35. Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy.
Vakrou S; Liu Y; Zhu L; Greenland GV; Simsek B; Hebl VB; Guan Y; Woldemichael K; Talbot CC; Aon MA; Fukunaga R; Abraham MR
Sci Rep; 2021 Jun; 11(1):13163. PubMed ID: 34162896
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.
Lim DS; Lutucuta S; Bachireddy P; Youker K; Evans A; Entman M; Roberts R; Marian AJ
Circulation; 2001 Feb; 103(6):789-91. PubMed ID: 11171784
[TBL] [Abstract][Full Text] [Related]
38. An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy.
Ibrahim AM; Roshdy M; Elshorbagy S; Hosny M; Halawa S; Yehia D; Elfawy HA; Eldessouki A; Mohamed F; Ellithy A; Abdelfattah M; Elsawy A; Elkhatib M; Allouba M; Elguindy A; Aguib Y; Yacoub M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003281
[TBL] [Abstract][Full Text] [Related]
39. Spatial Transcriptomic Analysis of Focal and Normal Areas of Myocyte Disarray in Human Hypertrophic Cardiomyopathy.
Laird J; Perera G; Batorsky R; Wang H; Arkun K; Chin MT
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628806
[TBL] [Abstract][Full Text] [Related]
40. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
